Ajooni Biotech Limited (NSE:AJOONI)

Ajooni Biotech Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	1,510	1,147	801.15	744.88	740.38	510.39
Other Revenue	11.79	11.79	1.39	-	-	-
Revenue	1,522	1,159	802.54	744.88	740.38	510.39
Revenue Growth (YoY)	44.77%	44.38%	7.74%	0.61%	45.06%	27.49%
Cost of Revenue	1,215	970.28	703.5	657.43	640.13	430.13
Gross Profit	307.3	188.44	99.04	87.45	100.24	80.26
Selling, General & Admin	135.23	123.95	64.3	50.88	56.03	51.83
Other Operating Expenses	95.84	14.04	7.06	6.8	11.57	11.77
Operating Expenses	247.96	148.92	80.1	67.73	78.7	69.37
Operating Income	59.33	39.52	18.94	19.72	21.54	10.89
Interest Expense	-1.62	-	-	-	-	-
Interest & Investment Income	8.88	8.88	5.06	2.05	0.01	0
Other Non Operating Income (Expenses)	0.47	-3.34	-5.29	-4.77	-5.4	-5.84
EBT Excluding Unusual Items	67.06	45.05	18.7	16.99	16.15	5.05
Other Unusual Items	-1.76	-1.76	-1.95	-1.23	-1.54	-0.01
Pretax Income	65.3	43.29	29.96	15.77	14.61	5.04
Income Tax Expense	16.11	9.57	8.35	4.52	4.12	1.31
Net Income	49.19	33.72	21.61	11.25	10.49	3.73
Net Income to Common	49.19	33.72	21.61	11.25	10.49	3.73
Net Income Growth	79.32%	56.02%	92.16%	7.24%	181.14%	7.57%
Shares Outstanding (Basic)	103	172	88	60	51	50
Shares Outstanding (Diluted)	103	172	88	60	51	50
Shares Change (YoY)	-51.30%	96.59%	46.51%	18.35%	1.00%	6.46%
EPS (Basic)	0.48	0.20	0.25	0.19	0.21	0.07
EPS (Diluted)	0.48	0.20	0.25	0.19	0.21	0.07
EPS Growth	268.24%	-20.64%	31.16%	-9.39%	180.50%	0.27%
Free Cash Flow	-	-197.69	173.09	-69.39	15.6	-23.71
Free Cash Flow Per Share	-	-1.15	1.98	-1.16	0.31	-0.47
Gross Margin	20.19%	16.26%	12.34%	11.74%	13.54%	15.73%
Operating Margin	3.90%	3.41%	2.36%	2.65%	2.91%	2.13%
Profit Margin	3.23%	2.91%	2.69%	1.51%	1.42%	0.73%
Free Cash Flow Margin	-	-17.06%	21.57%	-9.32%	2.11%	-4.65%
EBITDA	71.91	50.45	27.68	29.77	31.24	15.26
EBITDA Margin	4.72%	4.35%	3.45%	4.00%	4.22%	2.99%
D&A For EBITDA	12.58	10.94	8.74	10.05	9.7	4.37
EBIT	59.33	39.52	18.94	19.72	21.54	10.89
EBIT Margin	3.90%	3.41%	2.36%	2.65%	2.91%	2.13%
Effective Tax Rate	24.68%	22.11%	27.87%	28.68%	28.22%	26.02%
Revenue as Reported	1,535	1,168	823.08	747.82	740.76	510.56
Advertising Expenses	-	0.76	0.36	0.19	0.35	0.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.